Companies House · 05040260

GLENMARK PHARMACEUTICALS EUROPE LIMITED

UK registered company, private limited company, incorporated 10 Feb 2004.

Active
50
Public contracts
0
Spend payments
Total spend

GLENMARK PHARMACEUTICALS EUROPE LIMITED is a UK company registered at Companies House under number 05040260. This page links its registry record to its activity in UK public procurement — the contracts it has been awarded and the transparency-spend payments recorded against it.

Companies House record

Company number
05040260
Status
Active
Company type
Private Limited Company
Incorporated
10 Feb 2004
Country of origin
United Kingdom
Registered office
2-B LAXMI HOUSE, HARROW, MIDDLESEX, HA3 0BU
Nature of business (SIC)
46460 - Wholesale of pharmaceutical goods
Accounts category
FULL
View source on data.gov.uk

Public sector contracts

Contract awards linked to GLENMARK PHARMACEUTICALS EUROPE LIMITED.

ProcurementBuyerAwardedValue
NP35924b Rivaroxaban TabletsThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP Generic Medicines Transition Tender (October 2023)The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
NP Generic Medicines Transition Tender (October 2023)The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
NP30923 Psychiatry and Neurology MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP40923 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
NP40923 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
NP40923 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
NP43324 HIV Generic MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP36124 Antibiotic, Antiviral & Genito Urinary MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
ENT, Ophthalmology & Skin Medicines/Medical DevicesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
NP39724 Generic and Biosimilar Cancer MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP35925 Cardiovascular & Respiratory MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP35925 Cardiovascular & Respiratory MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP35925 Cardiovascular & Respiratory MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP35925 Cardiovascular & Respiratory MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Gastrointestinal, Endocrine, Nutrition & Blood MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Gastrointestinal, Endocrine, Nutrition & Blood MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Gastrointestinal, Endocrine, Nutrition & Blood MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP49425 Generic and Biosimilar Transition MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP49425 Generic and Biosimilar Transition MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
NP49425 Generic and Biosimilar Transition MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
HIV MedicinesThe Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
NHS National Generic Pharmaceuticals Interim 2 2020The NHS Commissioning Board (operating under the name of NHS England)
Invitation to offer for NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) for the treatment of HIV and Pre-Exposure Prophylaxis (PrEP) for the prevention of HIVNHS England
Prior Information Notice: NHS National Generic Pharmaceuticals - LenalidomideNHS England
NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals - 1 May 2023NHS England
Medicinal Products Dynamic Purchasing System (131864)Procurement & Logistics Service
NHS National Transition Framework for Apremilast, Pazopanib and DapagliflozinNHS England
NHS National Framework for Transition products commencing 1 May 2024NHS England
NHS National Framework for Transition products commencing 1 October 2024NHS England
NHS National Generic Pharmaceuticals Wave 15aNHS England
NHS National Generic Pharmaceuticals Wave 15aNHS England
Invitation to offer for NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 01 May 2025NHS England
NHS National Generic Pharmaceuticals Wave 15bNHS England
NHS Framework Agreement for Branded Medicines – NationalNHS England
NHS National Generic Pharmaceuticals Wave 13The NHS Commissioning Board (operating under the name of NHS England)
NHS National Generic Pharmaceuticals Wave 13The NHS Commissioning Board (operating under the name of NHS England)
NHS Framework Agreement for Branded Medicines - National TenderNHS England
NHS National Pharmaceuticals Transition 2022_1NHS England
NHS National Pharmaceuticals Transition 2022_1NHS England
NHS National Pharmaceuticals Transition 2022_1NHS England
NHS National Pharmaceuticals Transition 2022_2NHS England
NHS National Generic Pharmaceuticals Wave 14aNHS England
NHS National Generic Pharmaceuticals Wave 14aNHS England
NHS National Generic Pharmaceuticals Wave 14bNHS England
NHS National Generic Pharmaceuticals Wave 14bNHS England
NHS National Generic Pharmaceuticals Wave 14bNHS England

Supplier identities

How this company appears as a supplier across the data.

FAQs about GLENMARK PHARMACEUTICALS EUROPE LIMITED

Is GLENMARK PHARMACEUTICALS EUROPE LIMITED an active company?

GLENMARK PHARMACEUTICALS EUROPE LIMITED (company number 05040260) is recorded as "Active", incorporated on 10 Feb 2004.

What does GLENMARK PHARMACEUTICALS EUROPE LIMITED do?

Its Companies House nature-of-business (SIC) is: 46460 - Wholesale of pharmaceutical goods.

Has GLENMARK PHARMACEUTICALS EUROPE LIMITED won UK public-sector contracts?

Yes — 50 public-sector contract awards are linked to this company in our data.

Where is GLENMARK PHARMACEUTICALS EUROPE LIMITED based?

Its registered office is 2-B LAXMI HOUSE, HARROW, MIDDLESEX, HA3 0BU.

Understand any company's public-sector footprint

Enable links Companies House to live procurement and spend data — see contracts, buyers and payments for any UK supplier.

Get in touch with Enable